Table of Contents  

Surgical treatment of non-small-cell lung cancer

Stefan B Watzka, Tibor Krajc, Michael Rolf Mueller
Published in : HAMDAN MEDICAL JOURNAL ; Vol 9, No 1 (2016)
DOI : 10.7707/hmj.630


The current treatment of lung cancer is characterized by a broader interpretation of the term ‘targeted therapy’, which actually refers to the selective manipulation of molecular targets by neoadjuvant and/or adjuvant chemotherapy. The concept of targeted therapy may, however, also be translated to thoracic surgery in the sense that – despite greatly reduced invasiveness – treatment options with increased effectiveness and selectivity can be offered.In this paper, the current surgical treatment of all stages of non-small-cell lung cancer will be reviewed. The presented literature will show that – thanks to constantly renewing technology – radical and oncologically correct surgical treatment of bronchial carcinoma of the highest quality is possible for almost all stages. Thus, even locally advanced tumours can no longer be considered as an obstacle to cure. On the other hand – in tune with the overall trend of reduced invasiveness and enhanced effectiveness – sublobar resection for T1a tumours is gaining increasing acceptance amongst thoracic surgeons worldwide. The oncological radicality of limited lung resection can be further increased by innovative minimally invasive approaches to mediastinal lymphadenectomy. In conclusion, the paramount importance of radical mediastinal lymphadenectomy for patients’ survival is emphasized once more by the current literature.

View article in  :   PDF     HTML    

Add comment 

Home  Editorial Board  Search  Current Issue  Archive Issues  Announcements  Aims & Scope  About the Journal  How to Submit  Contact Us
Find out how to become a part of the HMJ  |   CLICK HERE >>
© Copyright 2012 - 2013 HMJ - HAMDAN Medical Journal. All Rights Reserved         Website Developed By Cedar Solutions INDIA